Literature DB >> 1491511

Studies on the antinephritic effects of plant components (6): antinephritic effects and mechanisms of phellodendrine (OB-5) on crescentic-type anti-GBM nephritis in rats (2).

T Hattori1, K Furuta, K Hayashi, T Nagamatsu, M Ito, Y Suzuki.   

Abstract

Effects of phellodendrine (OB-5) on crescentic-type anti-GBM nephritis in rats and the cell number of the various leukocyte subpopulations in the glomeruli of the nephritic rats were investigated. OB-5 at 25, 50 and 100 mg/kg/day, p.o. prevented the urinary protein excretion by the 19th day after i.v.-injection of anti-GBM serum. In the OB-5-treated rats, plasma cholesterol and creatinine contents were lower than those of the control rats throughout the 40-day experimental period. Histopathological observations demonstrated that OB-5 inhibited the incidence of crescent formation, adhesion and fibrinoid necrosis in the glomeruli by the 41st day. OB-5 did not affect the plasma antibody titer against rabbit gamma globulin. The increases in total leukocytes, macrophages, cytotoxic/suppressor T cells, Ia positive cells, and IL-2 receptor positive cells in the glomeruli in OB-5, 100 mg/kg-treated rats as well as those of the animals treated with azathioprine or cyclosporin A were lower than those of the anti-GBM nephritic control. These results indicate that OB-5 was effective in crescentic-type anti-GBM nephritis and the antinephritic mechanisms of this agent may be due to its ability to inhibit the proliferation or the migration of macrophages and cytotoxic T lymphocytes in the glomeruli.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491511     DOI: 10.1254/jjp.60.187

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  2 in total

1.  Pharmacokinetic interaction between rhynchopylline and pellodendrine via CYP450 enzymes and P-gp.

Authors:  Qingzhen Meng; Yongheng Cheng; Cui Zhou
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

2.  Utilizing network pharmacology and experimental validation to investigate the underlying mechanism of phellodendrine on inflammation.

Authors:  Lili Hu; Jue Wang; Na Wu; Xiaoge Zhao; Donghui Cai
Journal:  PeerJ       Date:  2022-09-23       Impact factor: 3.061

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.